Close
  • Home

CAR-T Digest - August 2020

CAR-T Digest - August 2020

CAR-T Digest - August 2020

CAR-T Digest - August 2020

Weekly Digest – 31 October to 06 November 2026

Regulatory  ·  Weekly Digest - 31 October to 06 November 2026
NMPA grants priority review to Hengrui’s Trastuzumab Rezetecan NDA for 1L HER2-positive breast cancer

Weekly Digest – November 2026 Weekly Digest – November 2026 30 October 2026: NMPA grants Priority Review to Hengrui’s Trastuzumab Rezetecan NDA for 1L HER2-positive Breast cancer Hengrui Medicine’s subsidiary, Suzhou Shengdiya, received NMPA acceptance and Priority Review for SHR-A1811, a HER2-targeted […]

by Sandhya Ramalingam

Continue Reading
Regulatory  ·  Weekly Digest - 31 October to 06 November 2026
SEC recommends approval for additional indication of AstraZeneca’s anti-cancer drug

Weekly Digest – November 2026 Weekly Digest – November 2026 03 November 2026: SEC recommends approval for additional indication of AstraZeneca’s anti-cancer drug The Subject Expert Committee recommended approval of an additional indication for AstraZeneca’s datopotamab deruxtecan in adults with unresectable or […]

by Sandhya Ramalingam

Continue Reading
Regulatory  ·  Weekly Digest - 31 October to 06 November 2026
Alphamab oncology announces IND application for innovative EGFR/HER3 dual payload bispecific ADC JSKN021 was approved by the FDA

Weekly Digest – November 2026 Weekly Digest – November 2026 02 November 2026: Alphamab oncology announces IND application for innovative EGFR/HER3 dual payload bispecific ADC JSKN021 was approved by the FDA Alphamab Oncology announced that the FDA has approved the IND application for […]

by Sandhya Ramalingam

Continue Reading
Clinical  ·  Weekly Digest - 31 October to 06 November 2026
CSPC Pharmaceutical Group has initiated phase 1/2 clinical trial of SYS6043 for the Solid tumor in China

Weekly Digest – November 2026 Weekly Digest – November 2026 30 October 2026: CSPC Pharmaceutical Group has initiated Phase 1/2 clinical trial of SYS6043 for the Solid tumor in China CSPC Pharmaceutical Group has initiated the first-site Phase 1/2 clinical […]

by Sandhya Ramalingam

Continue Reading
Deals  ·  Weekly Digest - 31 October to 06 November 2026
Sino biopharmaceutical enters strategic oncology partnership with Boehringer Ingelheim valued at up to US$7 billion

Weekly Digest – November 2026 Weekly Digest – November 2026 04 November 2026: Sino Biopharmaceutical enters strategic oncology partnership with Boehringer Ingelheim valued at up to US$7 billion Sino Biopharmaceutical entered its second oncology collaboration with Boehringer Ingelheim, covering six […]

by Sandhya Ramalingam

Continue Reading
Deals  ·  Weekly Digest - 31 October to 06 November 2026
Telix Joins Thera4Care with TLX400-Tx to accelerate translation of next generation FAP-targeting theranostics

Weekly Digest – November 2026 Weekly Digest – November 2026 05 November 2026: Telix Joins Thera4Care with TLX400-Tx to accelerate translation of next generation FAP-targeting theranostics Telix joined Thera4Care, a European theranostics initiative involving 27 partners, to advance collaborative research and […]

by Sandhya Ramalingam

Continue Reading


Contact:

  info@ciscientists.com

 +1-908-212-7484

Optimal Dose

For a subscription, please provide your email id